Showing results (1-10 of 3,856) with videos related to
Sort By:
Pageof 386
Liver|September 11, 2002
Albumin dialysis: single pass vs. recirculation (MARS)P Peszynski, S Klammt, E Peters, et al.Metabolic Brain Disease|February 27, 2003
Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS--a review of clinical, biochemical, and electrophysiological dataS Mitzner, J Loock, P Peszynski, et al.Current Opinion in Nephrology and Hypertension|November 14, 2001
Albumin dialysis using the molecular adsorbent recirculating systemS R Mitzner, J Stange, S Klammt, et al.Liver|September 11, 2002
Extracorporeal liver support by recirculating albumin dialysis: analysing the effect of the first clinically used generation of the MARSystemS Klammt, J Stange, S R Mitzner, et al.Journal of the American Society of Nephrology : JASN|March 17, 2001
Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failureS R Mitzner, J Stange, S Klammt, et al.Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|January 10, 2002
Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating systemS R Mitzner, S Klammt, P Peszynski, et al.Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|April 16, 2005
[Extracorporeal blood purification in severe liver failure with the albumin dialysis MARS -- impact on relevant intensive care parameters]S Mitzner, S Klammt, J Stange, et al.Artificial Organs|September 1, 1993
Dialysis against a recycled albumin solution enables the removal of albumin-bound toxinsJ Stange, W Ramlow, S Mitzner, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1995
Primary or established liver cells for a hybrid liver? Comparison of metabolic featuresJ Stange, S Mitzner, M Strauss, et al.The International Journal of Artificial Organs|November 1, 1996
A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liverJ Stange, S MitznerPageof 386